SASKATOON, Saskatchewan, July 02, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 827,603 options to purchase common shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.48 and an expiry date of July 1, 2035, subject to approval of the TSX Venture Exchange.
PharmaCorp Announces Grant of Stock Options
Seeking Alpha / 14 hours ago 3 Views
Comments